Replies to post #180532 on Biotech Values

[DewDiligence]

Still that begs the question how can Abbvie patent Pharmasset’s compound…?

ABBV didn’t patent Sovaldi per se, so ownership of the compound was not germane to patentability; rather, ABBV patented the “method of use” in combining Sovaldi with Ledipasvir (among various other all-oral combinations).